Research Article

Clinical and Polysomnographic Evaluation of Morning Headache in Patients with Obstructive Sleep Apnea Syndrome

Volume: 7 Number: 3 December 26, 2022
TR EN

Clinical and Polysomnographic Evaluation of Morning Headache in Patients with Obstructive Sleep Apnea Syndrome

Abstract

Aim: The aim of the present study was to investigate the clinical and polysomnographic (PSG) characteristics in patients with PSG-verified obstructive sleep apnea syndrome (OSAS) with or without morning headache (MH) and to evaluate the response to nasal continuous positive airway pressure (n-CPAP) treatment. Methods: Patients who were referred to the sleep laboratory due to suspected OSAS were prospectively evaluated and divided into two groups: with MH (group 1) and without MH (group 2). Age, sex, body mass index (BMI), Epworth Sleepiness Scale (ESS), Pittsburg Sleep Quality Index (PSQI), Hamilton Depression Scale (HDS), Hamilton Anxiety Scale (HAS), and PSG variables were compared. Patients in group 1 who received n-CPAP treatment were also evaluated for headache persistence. Results: Seventy-eight patients with OSAS were included and 28 (35.9%) patients reported MH. Female gender and mean BMI were significantly higher in group 1 (43% vs. 20%, p=0.03; 33.14.9 vs. 30.64.8 kg/m2, p=0.04, respectively). The ESS was higher in group 1 (10.8±4.4 vs. 8.4±4.1, p=0.02). PSQI score, HDS, and HAS did not differ between the groups. Average SpO2 (903.64 vs. 92.42.88) and minimum SpO2 (78.1±10.7 vs. 83.2±6.8) were significantly lower in the MH group (p=0.02 and p=0.03). In addition, the duration of SpO2 <90 was significantly higher in the MH group (17.9817.67 vs. 11.0712.37, p=0.04). Nineteen (86.4%) of the 22 patients who received n-CPAP treatment were headache free. Conclusion: Minimum SpO2 levels and duration of desaturation during sleep were associated with MH. The other risk factors were female gender and higher BMI. N-CPAP therapy is an effective treatment for patients with MH.

Keywords

References

  1. 1. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
  2. 2. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6:e1000132.
  3. 3. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006-14.
  4. 4. Fietze I, Laharnar N, Obst A, Ewert R, Felix SB, Garcia C, et al. Prevalence and association analysis of obstructive sleep apnea with gender and age differences - Results of SHIP-Trend. J Sleep Res 2019;28:e12770.
  5. 5. Sand T, Hagen K, Schrader H. Sleep apnoea and chronic headache. Cephalalgia 2003;23:90-5.
  6. 6. Mitsikostas DD, Vikelis M, Viskos A. Refractory chronic headache associated with obstructive sleep apnoea syndrome. Cephalalgia 2008;28:139-43.
  7. 7. Johnson KG, Ziemba AM, Garb JL. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea: a retrospective analysis. Headache 2013;53:333-43.
  8. 8. Neau JP, Paquereau J, Bailbe M, Meurice JC, Ingrand P, Gil R. Relationship between sleep apnoea syndrome, snoring and headaches. Cephalalgia 2002;22:333-9.

Details

Primary Language

English

Subjects

​Internal Diseases

Journal Section

Research Article

Publication Date

December 26, 2022

Submission Date

October 19, 2022

Acceptance Date

December 24, 2022

Published in Issue

Year 2022 Volume: 7 Number: 3

Vancouver
1.Senay Yildiz Celik, Özlem Öz. Clinical and Polysomnographic Evaluation of Morning Headache in Patients with Obstructive Sleep Apnea Syndrome. Arch Clin Exp Med [Internet]. 2022 Dec. 1;7(3):72-6. Available from: https://izlik.org/JA54GG49PL